Scaffold Technology Market to Garner $1.25 Billion, Globally, by 2027 at 16.9% CAGR: Allied Market Research

Advantages of 3D culture techniques over 2D methods, surge in demand for organ transplantation, and increase in investment for R&D activities have boosted the growth of the global scaffold technology market

News provided by

Allied Market Research

May 17, 2021, 09:00 ET

PORTLAND, Ore., May 17, 2021 /PRNewswire/ -- Allied Market Research recently published a report, titled, "Scaffold Technology Market by Product Type (Natural Scaffold and Synthetic Scaffold), by Type (Macro-porous Scaffolds, Micro-porous Scaffolds, Nano-porous Scaffolds, Solid Scaffolds), Application (Cancer Cell Research, Stem Cell Research, Drug Discovery, Regenerative Medicine, and Others), and End User (Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2020-2027". As per the report, the global scaffold technology industry was pegged at $398.91 million in 2019, and is estimated to reach $1.25 billion by 2027, growing at a CAGR of 16.9% from 2020 to 2027.

Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/11468

Drivers, restraints, and opportunities

Advantages of 3D culture techniques over 2D methods, rise in use of 3D cell cultures for cancer research, surge in demand for organ transplantation, and increase in investment for R&D activities have boosted the growth of the global scaffold technology market. However, high implementation costs and irregularity in 3D cell culture outcomes hinder the market growth. On the contrary, technological advancements are expected to open lucrative opportunities for the market players in the future.

Covid-19 scenario:

Rise in R&D activities has created a massive demand for scaffold-based platforms in 3D cell cultures to develop a viable treatment against Covid-19.
However, prolonged lockdown resulted in an inconsistent and interrupted supply chain and lack of skilled human resources.
Several countries adopted nationwide lockdown to maintain social distancing. Thus, the trade and transport restrictions, cross-border movement controls, and quarantine measures have minimized the supply of scaffold-based components required for 3D cell cultures.

The synthetic scaffold segment to manifest the highest CAGR through 2027

By product type, the synthetic scaffold segment is estimated to register the highest CAGR of 17.9% during the forecast period, due to its efficiency over biologically derived materials. However, the natural scaffold segment held the lion's share in 2019, accounting for nearly two-thirds of the global scaffold technology market, owing to its properties such as biocompatibility, non-toxicity, biodegradability, good cell recognition properties, and easy functionalization.

Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/11468

The cancer research segment held the lion's share

By application, the cancer research segment held the largest share in 2019, contributing to nearly one-third of the global scaffold technology market, due to rise in adoption of scaffold-based 3D cell culture in cancer research and the drug discovery and increase in prevalence of cancer across the world. However, the regenerative medicine segment is projected to portray the highest CAGR of 17.6% from 2020 to 2027, as scaffold initiates tissue growth in regenerative medicine, and its presence allows cells to generate biological structural components of the extracellular matrix in a culture environment.

North America dominated the market in 2019

By region, the global scaffold technology market across North America held the lion's share in 2019, contributing to around two-fifths of the market, due to presence of large pharmaceutical and biotechnology companies that use scaffold technology in 3D culture in collaboration with research institutes and clinical laboratories for developing regenerative medicines and drug discovery & development. However, the market across Asia-Pacific is estimated to register the highest CAGR of 18.7% during the forecast period, due to economic development and low operating costs.

Major market players

3D Biotek LLC
Agilent Technologies, Inc. (Biotek)
Advanced Biomatrix, Inc.
Corning Incorporated
BioVison, Incorporated
PromoCell GmbH
Merck KGaA (Sigmaaldrich)
Synthecon, Incorporated
Reprocell, Incorporation
Thermo Fisher Scientific Inc.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.

Stem Cell Banking Market - Global Opportunity Analysis and Industry Forecast, 2019-2027

Cell Culture Market - Global Opportunity Analysis and Industry Forecast, 2019-2027

Regenerative Medicine Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

Bioinformatics Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

Bio-implants Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

Cardiac Biomarkers Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022, 1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research